trending Market Intelligence /marketintelligence/en/news-insights/trending/mceryq3wypw9uabr0gywra2 content esgSubNav
In This List

Report: Nektar Therapeutics exploring strategic options

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Report: Nektar Therapeutics exploring strategic options

Nektar Therapeutics is exploring strategic options, including a possible sale of the company, Bloomberg News reported, citing people familiar with the matter.

The pharmaceuticals company is also considering partnerships and licensing deals, according to the publication.

No final decisions have been made and warned that negotiations may not lead to an agreement, the sources said.